Loading...

© 2026 MedXY

Contact us About us Privacy Policy MedXY story

MedXY AI/MedXY News/Tag: ophthalmology

MedXY News

EnglishTag

ophthalmology

32 · 20 / page

Ask MedXY AI

type 2 diabetes clinical trial heart failure immunotherapy obesity cardiovascular risk atrial fibrillation critical care biomarkers Cardiology clinical trials oncology Hypertension artificial intelligence public health diabetes Alzheimer's disease type 1 diabetes breast cancer cardiovascular disease Mortality Pregnancy

Latest news

Tag

AI Writing Vocabulary in Ophthalmology: Faster Non-Native Adoption, Unchanged Outcomes

AIophthalmologyAI writing

AI Writing Vocabulary in Ophthalmology: Faster Non-Native Adoption, Unchanged Outcomes

By MedXY|Aug 25, 2026

This study examines the increased use of AI-associated writing vocabulary in ophthalmology articles, revealing faster adoption by non-native English authors without changes in publication frequency or journal quality.

Ultra-Long-Distance Robotic-Assisted Subretinal Injection for Submacular Hemorrhage: A Case Report

newssubmacular hemorrhagetelemedicine

Ultra-Long-Distance Robotic-Assisted Subretinal Injection for Submacular Hemorrhage: A Case Report

By MedXY|Aug 23, 2026

This report describes the successful ultra-long-distance robotic-assisted subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage, demonstrating procedural feasibility and safety across 4000 km.

Innovative Prosthetic Capsular Bag Enables Secure Scleral Fixation of Intraocular Lenses Without Capsular Support

newsIntraocular Lensophthalmology

Innovative Prosthetic Capsular Bag Enables Secure Scleral Fixation of Intraocular Lenses Without Capsular Support

By MedXY|Aug 23, 2026

A first-in-human study demonstrates the safety and efficacy of a novel prosthetic capsular bag for scleral fixation of intraocular lenses in eyes lacking capsular or zonular support, showing promising visual outcomes and low complication ra

Predicting the Future of Uveitis: Bridging Subspecialty Divides Through Knowledge Dissemination and Technology

newsMedical EducationUveitis

Predicting the Future of Uveitis: Bridging Subspecialty Divides Through Knowledge Dissemination and Technology

By MedXY|Aug 17, 2026

This article examines the evolving landscape of uveitis care, emphasizing the need to unify ophthalmologic subspecialties through education and artificial intelligence to improve outcomes for this vision-threatening condition.

Increased Risk of Dry Eye Disease in Patients with Chronic Pain Conditions: Insights from a Large Retrospective Cohort Study

newschronic paindry eye disease

Increased Risk of Dry Eye Disease in Patients with Chronic Pain Conditions: Insights from a Large Retrospective Cohort Study

By MedXY|Jul 20, 2026

Chronic pain conditions significantly elevate the risk of developing dry eye disease, including cases requiring prescription therapy, emphasizing the need for integrated clinical assessment and management.

Bridging the Gap: Geographic Disparities in Access to Diabetic Retinopathy Care Across the United States

Diabetes & EndocrinologyGeographic Disparitieskhả năng tiếp cận chăm sóc

Bridging the Gap: Geographic Disparities in Access to Diabetic Retinopathy Care Across the United States

By MedXY|Jul 17, 2026

This study reveals significant urban-rural disparities in access to diabetic retinopathy diagnostic and therapeutic services in the U.S., underscoring the need for targeted strategies to improve care in non-urban areas.

Artificial Intelligence Smart Eyeglasses for the Detection and Description of Stationary Objects: A Pilot Feasibility Study

AIartificial intelligencecase report

Artificial Intelligence Smart Eyeglasses for the Detection and Description of Stationary Objects: A Pilot Feasibility Study

By MedXY|Jul 15, 2026

A pilot study evaluating Ray-Ban Meta AI eyeglasses demonstrated high accuracy in single object identification and moderate performance in descriptive tasks, suggesting promise for aiding individuals with low vision.

A Consensus Reference Standard for AI Screening of Age-Related Macular Degeneration: What Clinicians and Developers Need to Know

AIage-related macular degenerationAI screening

A Consensus Reference Standard for AI Screening of Age-Related Macular Degeneration: What Clinicians and Developers Need to Know

By MedXY|Jul 15, 2026

A 2026 expert consensus defines an image-based reference standard to validate AI screening algorithms for age-related macular degeneration (AMD), endorsing Beckman grading and routine OCT use while clarifying referral thresholds and areas o

Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes: A Case Series Analysis

Diabetes & Endocrinologyblood pressure assessmentcase report

Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes: A Case Series Analysis

By MedXY|Jul 9, 2026

This case series reveals a high prevalence of uncontrolled hypertension among diabetic patients visiting ophthalmology clinics and highlights the importance of in-clinic blood pressure screening to identify and manage cardiovascular risk.

Disparities in Access to Intravitreal Anti-VEGF Therapies Among Medicare Advantage Versus Fee-for-Service Beneficiaries

newsDrug UtilizationFee-for-Service

Disparities in Access to Intravitreal Anti-VEGF Therapies Among Medicare Advantage Versus Fee-for-Service Beneficiaries

By MedXY|Jul 5, 2026

Medicare Advantage beneficiaries receive fewer higher-cost anti-VEGF injections compared to Fee-for-Service patients, highlighting potential access disparities to newer ophthalmic therapies.

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial

Infectious Diseasesclinical trialInfectious Keratitis

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial

By MedXY|Jun 29, 2026

A 12-month follow-up of the REAGIR trial found no significant benefit of adjunctive rose bengal photodynamic therapy with green light over sham treatment in improving visual acuity, scar size, or complication rates in infectious keratitis.

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study

Diabetes & EndocrinologyGLP-1 receptor agonistneovascular age-related macular degeneration

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study

By MedXY|Jun 10, 2026

In a large OHDSI network study of adults with type 2 diabetes, semaglutide was not associated with a higher or lower risk of neovascular age-related macular degeneration.

Immune Checkpoint Inhibitor-Associated Uveitis: Comparative Risk Across Cancers and Drug Classes

newsimmune checkpoint inhibitorsmelanoma

Immune Checkpoint Inhibitor-Associated Uveitis: Comparative Risk Across Cancers and Drug Classes

By MedXY|Jun 4, 2026

A multicenter study found that immune checkpoint inhibitor–associated uveitis risk varies by cancer type and drug class, with melanoma showing the highest intrinsic risk and RCC risk largely linked to ipilimumab/nivolumab exposure.

Anesthesia-Related Neurologic Risk in Patients of Venezuelan Descent: Implications for Ophthalmology

Anesthesiologymitochondrial DNAneurologic injury

Anesthesia-Related Neurologic Risk in Patients of Venezuelan Descent: Implications for Ophthalmology

By MedXY|May 21, 2026

A rare, severe neurologic complication has been linked to general anesthesia in patients of maternal Venezuelan descent. Ophthalmologists should screen for ancestry and family history, involve anesthesiology early, and consider genetic eval

Optimizing Geographic Atrophy Clinical Trial Design: The Role of Run-In Phases, Single-Arm Architectures, and Functional Endpoints

Clinical UpdatesGeographic Atrophyophthalmology

Optimizing Geographic Atrophy Clinical Trial Design: The Role of Run-In Phases, Single-Arm Architectures, and Functional Endpoints

By MedXY|May 20, 2026

This review synthesizes evidence on improving geographic atrophy trial efficiency through innovative run-in phases, single-arm designs, and superior functional biomarkers like microperimetry to reduce required sample sizes.

GLP-1 Weight-Loss and Diabetes Drugs: What Eye Specialists Say About NAION Risk

newsGLP-1 receptor agonistsNAION

GLP-1 Weight-Loss and Diabetes Drugs: What Eye Specialists Say About NAION Risk

By MedXY|May 18, 2026

A new consensus statement advises cautious, shared decision-making about GLP-1 receptor agonists and NAION risk, noting that current evidence is observational, conflicting, and suggests any absolute risk increase is small.

Seeing the Invisible: New Global Consensus on Using Advanced Imaging to Track Uveitis Activity

newsclinical guidelinesDisease Monitoring

Seeing the Invisible: New Global Consensus on Using Advanced Imaging to Track Uveitis Activity

By MedXY|Mar 24, 2026

A global task force has established new standardized imaging measures to define disease activity in non-infectious posterior uveitis, bridging a critical gap in clinical diagnosis and trial monitoring.

$LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia$

newsCataract surgeryIOL Calculation

LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia

By MedXY|Mar 19, 2026

A new IOL power calculation formula, LISA MRS, demonstrates superior accuracy for cataract patients with prior myopic refractive surgery, significantly outperforming existing formulas in eyes with axial lengths of 28 mm or greater by utiliz

The Persistence of Ophthalmic Scarcity: A 23-Year Longitudinal Analysis of Drug Shortages in the United States

Clinical UpdatesDrug Shortagesophthalmology

The Persistence of Ophthalmic Scarcity: A 23-Year Longitudinal Analysis of Drug Shortages in the United States

By MedXY|Mar 20, 2026

This review analyzes ophthalmic drug shortages from 2001 to 2024, revealing that eye medications face longer shortage durations than other drug classes, significantly influenced by patent status and manufacturing transparency.

Impact of Long-Term Intravitreal Anti-VEGF Injections on Cataract Progression and Surgical Outcomes

newsAnti-VEGFBệnh lý võng mạc

Impact of Long-Term Intravitreal Anti-VEGF Injections on Cataract Progression and Surgical Outcomes

By MedXY|Mar 16, 2026

A longitudinal study of 603 patients demonstrates that chronic intravitreal anti-VEGF therapy significantly accelerates cataract development, particularly posterior subcapsular opacities, resulting in an eightfold increased risk for catarac

Ask MedXY AI

Most popular

Intimate Health

Five Benefits for Women Continuing Sexual Activity After Menopause

Intimate Health

Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

How often should a couple have sex?

Intimate Health

Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Intimate Health

What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

MedXY News - ophthalmology